Synergistic effects of plasma-activated medium and chemotherapeutic drugs in cancer treatment
Authors:
- 7 March 2018
- journal article
- research article
- Published by IOP Publishing in Journal of Physics D: Applied Physics
- Vol. 51 (13) , 13LT01
Abstract
Chemotherapy is an important treatment method for metastatic cancer, but the drug-uptake efficiency of cancer cells needs to be enhanced in order to diminish the side effects of chemotherapeutic drugs and improve survival. The use of a nonequilibrium low-temperature atmospheric-pressure plasma jet (APPJ) has been demonstrated to exert selective effects in cancer therapy and to be able to enhance the uptake of molecules by cells, which makes an APPJ a good candidate adjuvant in combination chemotherapy. This study estimated the effects of direct helium-based APPJ (He-APPJ) exposure (DE) and He-APPJ-activated RPMI medium (PAM) on cell viability and migration. Both of these treatments decreased cell viability and inhibited cell migration, but to different degrees in different cell types. The use of PAM as a culture medium resulted in the dialkylcarbocyanine (DiI) fluorescent dye entering the cells more efficiently. PAM was combined with the anticancer drug doxorubicin (Doxo) to treat human heptocellular carcinoma HepG2 cells and human adenocarcinomic alveolar basal epithelial A549 cells. The results showed that the synergistic effects of combined PAM and Doxo treatment resulted in stronger lethality in cancer cells than did PAM or Doxo treatment alone. To sum up, PAM has potential as an adjuvant in combination with other drugs to improve curative cancer therapies.Keywords
This publication has 31 references indexed in Scilit:
- Cold atmospheric plasma in cancer therapyPhysics of Plasmas, 2013
- Cold Atmospheric Air Plasma Sterilization against Spores and Other Microorganisms of Clinical InterestApplied and Environmental Microbiology, 2012
- Cold plasma selectivity and the possibility of a paradigm shift in cancer therapyBritish Journal of Cancer, 2011
- A key inactivation factor of HeLa cell viability by a plasma flowJournal of Physics D: Applied Physics, 2011
- Cold Spark Discharge Plasma Treatment of Inflammatory Bowel Disease in an Animal Model of Ulcerative ColitisPlasma Medicine, 2011
- Induction of cell growth arrest by atmospheric non-thermal plasma in colorectal cancer cellsJournal of Biotechnology, 2010
- Endothelial Cell Proliferation is Enhanced by Low Dose Non-Thermal Plasma Through Fibroblast Growth Factor-2 ReleaseAnnals of Biomedical Engineering, 2009
- Cell permeabilization using a non-thermal plasmaNew Journal of Physics, 2009
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nature Reviews Drug Discovery, 2009
- Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodelingParticle and Fibre Toxicology, 2009